Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Submucosal methylprednisolone versus dexamethasone versus control before third molar surgery
ACTRN12619001349134Phase 3Not yet recruiting
- Sponsor
- Dr Kinza Ayub
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone and methylprednisolone in pericoronitis (3 arms), sponsored by Dr Kinza Ayub. Primary endpoints: Postoperative trismus and Postoperative swelling. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
dexamethasonemethylprednisolone
03
Conditions
pericoronitis
Beyond the preview
Go deeper on ACTRN12619001349134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001349134.